Eagle Bay Advisors’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-458	Closed	-$150K	–	956
2024 Q4	$150K	Sell	458 -13	-3%	-$4.09K	0.09%	141
2024 Q3	$141K	Sell	471 -29	-6%	-$8.88K	0.05%	222
2024 Q2	$165K	Sell	500 -77	-13%	-$27.2K	0.1%	138
2024 Q1	$228K	Sell	577 -270	-32%	-$99.9K	0.14%	117
2023 Q4	$298K	Sell	847 -239	-22%	-$84.6K	0.19%	90
2023 Q3	$407K	Buy	1,086 +197	+22%	+$76.2K	0.19%	79
2023 Q2	$340K	Sell	889 -49	-5%	-$17.5K	0.19%	77
2023 Q1	$325K	Sell	938 -104	-10%	-$30.4K	0.18%	85
2022 Q4	$245K	Buy	1,042 +490	+89%	+$116K	0.14%	111
2022 Q3	$136K	Sell	552 -300	-35%	-$91.4K	0.08%	158
2022 Q2	$258K	Buy	852 +310	+57%	+$101K	0.16%	105
2022 Q1	$222K	Sell	542 -80	-13%	-$31.3K	0.18%	89
2021 Q4	$292K	Buy	622 +58	+10%	+$25K	0.19%	80
2021 Q3	$239K	Buy	564 +161	+40%	+$67.9K	0.13%	116
2021 Q2	$145K	Buy	+403	New	+$133K	0.12%	114